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Abstract
Background: The interest in microfluidics and surface patterning is increasing as the use of these
technologies in diverse biomedical applications is substantiated. Controlled molecular and cellular
surface patterning is a costly and time-consuming process. Methods for keeping multiple separate
experimental conditions on a patterned area are, therefore, needed to amplify the amount of
biological information that can be retrieved from a patterned surface area. We describe, in three
examples of biomedical applications, how this can be achieved in an open microfluidic system, by
hydrodynamically guiding sample fluid over biological molecules and living cells immobilized on a
surface.
Results: A microfluidic format of a standard assay for cell-membrane integrity showed a fast and
dose-dependent toxicity of saponin on mammalian cells. A model of the interactions of human
mononuclear leukocytes and endothelial cells was established. By contrast to static adhesion assays,
cell-cell adhesion in this dynamic model depended on cytokine-mediated activation of both
endothelial and blood cells. The microfluidic system allowed the use of unprocessed blood as
sample material, and a specific and fast immunoassay for measuring the concentration of C-reactive
protein in whole blood was demonstrated.
Conclusion:  The use of hydrodynamic guiding made multiple and dynamic experimental
conditions on a small surface area possible. The ability to change the direction of flow and produce
two-dimensional grids can increase the number of reactions per surface area even further. The
described microfluidic system is widely applicable, and can take advantage of surfaces produced by
current and future techniques for patterning in the micro- and nanometer scale.
Background
Microfluidic technology holds promise for advances in
analytical biochemistry, drug discovery and development,
and cellular and tissue research and engineering. Han-
dling of fluids in structures of the micrometer scale gives
rise to fluid dynamics that are very different from those at
the macroscale [1,2]. The fluid dynamics, the large ratio of
surface area to volume, and the significant surface tension
forces of microfluidic systems can be exploited to achieve
fast and sensitive bioanalysis [1,3]. Moreover,
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microfluidics is useful when only a minute amount of
sample material is available for analysis. In drug discovery
and development, microfluidic systems for high-through-
put screening and target validation are being developed
[4]. In tissue engineering, microfluidics is useful for pat-
terning of cells in tissue architectures, and for local deliv-
ery of chemical agents [5]. Microfluidic systems can
provide the flow velocities present in the vascular system,
which is important for endothelial-cell morphology and
function [6]. Microfluidic-based assays should, therefore,
be better suited than the classical static assay systems for
studying endothelial cells and their interactions with
blood cells, cancer cells and circulating stem and progen-
itor cells.
Several techniques for patterning of surfaces with mam-
malian cells have been described [7]. There are two main
approaches: (i) the cells can be exposed to whole surfaces
altered only in certain regions [8–10], for example, print-
ing of a cell substrate onto a surface will lead to cell adhe-
sion only on the printed regions of the surface; and (ii)
alternatively, the cells can be exposed to only a part of the
surface, for example, by placing stamps with accessible
chambers on the surface [11], or by laminar flow pattern-
ing in capillary systems [12], or by using a combination of
these methods [13]. Controlled molecular and cellular
patterning is, however, a costly and time-consuming proc-
ess. Methods for keeping multiple separate experimental
conditions on the patterned area would increase the
number of tests or reactions, and thus amplify the amount
of biological information that could be retrieved from a
surface area. The present article describes how this can be
achieved in a microfluidic system, by hydrodynamically
guiding sample fluid over biological molecules and living
cells immobilized on a surface.
The microfluidic system presented here consists of a reus-
able microfluidic chip connected to fluid pumps by fine
capillaries, and a docking station which holds the chip
and a slide with immobilized biological material (Figure
1A). The chip and the surface of the slide confine a flow
chamber, in which lanes of the immobilized biological
material are sequentially exposed to sample. Two guiding
streams are used to obtain the desired flow trajectory and
width of sample stream in the flow chamber (Figure 1B).
The narrow tubing and small dimensions of the flow
chamber eliminates turbulence phenomena. Mixing
between guiding and sample fluids is, therefore, due only
to diffusion, which is a relatively slow process. The dock-
ing station fits a standard microscope, allowing observa-
tion and recording of events occurring in the flow
chamber.
Three biomedical applications of hydrodynamic guiding
are demonstrated: (i) an assay for cell-membrane integrity
on exposure to substances, (ii) a leukocyte-endothelial
cell adhesion model, and (iii) an assay for measuring the
concentration of C-reactive protein (CRP) in whole
blood.
Results
Variation within and between lanes produced by 
hydrodynamic guiding
Fluorescein-labeled biotin was guided sequentially in ten
lanes over immobilized streptavidin. The flow direction
was then changed, and another ten lanes were guided over
the same area, but perpendicularly to the first set of lanes.
The even shape of the resulting two-dimensional grid,
shown in Figure 2, illustrates the small variation within
and between lanes produced by hydrodynamic guiding.
The fluorescence intensity decreased slightly along the
length of the lanes.
Cell-membrane integrity of mammalian cells on exposure 
to saponin
Saponin was guided over chinese hamster ovary (CHO)
cells, and the cells were immediately stained to determine
their viability. The ratio of dead to viable cells increased
with increasing concentration of saponin, as shown in
Figure 3. On exposure to saponin at a concentration of
0.013% (w/v) for 30 s (shear stress of 15 dyn/cm2), 45%
of the CHO cells died. Almost all CHO cells died when
exposed to saponin at a concentration of 0.020% (w/v).
Adhesion of mononuclear blood cells to endothelial cells 
under laminar shear stress
Human umbilical vein endothelial cells (HUVEC) were
incubated with tumor necrosis factor (TNF)-α for 6 hr and
then stained for CD54 (ICAM-1), CD62E (E-selectin) and
CD106 (VCAM-1) by secondary immunofluorescence.
CD54, CD62E and CD106 were all induced by TNF-α,
and were present in the plasma membrane and around
the nuclei (Figure 4A). A primary antibody with an irrele-
vant specificity (isotype control) did not give staining of
the cells. Mononuclear leukocytes from two individuals
were stained to fluoresce green, given macrophage inflam-
matory protein (MIP)-1α and monocyte chemoattractant
protein (MCP)-1 chemokines, and then guided over a
confluent monolayer of TNF-α-activated HUVEC (shear
stress of 0.75 dyn/cm2). Mononuclear leukocytes not acti-
vated with MCP-1 and MIP-1α showed only very limited
adhesion to TNF-α-activated HUVEC, whereas activation
with these chemokines increased the number of adherent
leukocytes 14–25 fold (Figure 4B). Adhesion of the leuko-
cytes decreased with time of preincubation with the chem-
okines, and no or very few leukocytes adhered when
preincubated for more than 40 min with the chemokines
(Figure 4C). Chemokine-activated mononuclear leuko-
cytes from either of the individuals neither adhered toBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/10
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The microfluidic system Figure 1
The microfluidic system. (A): The reusable microfluidic chip and a slide with immobilized biological material are inserted in 
the docking station. When closed, the docking station provides the mechanical force for sealing of the flow chamber between 
the chip and the slide. The loaded docking station is placed on the stage of a microscope, and the capillaries from the microchip 
are connected to a liquid-controlling unit (not shown). (B): Inside the flow chamber, lanes of the immobilized biological material 
are sequentially exposed to sample. Two guiding streams (arrows) are used to obtain the desired flow trajectory of the sample 
stream, and these form a sheath on both sides of the sample, confining it between the guiding streams and the roof and the 
floor of the flow chamber. The distance between the sample stream and the previous lane is fully adjustable, and overlapping 
lanes can be produced. Adjusting guiding and sample flows controls the width of the sample stream, which can be as narrow as 
25 µm, given that a precise fluid-controlling unit is used, and as wide as the chip allows. In the present study, 50–500-µm-wide 
sample streams were positioned in the central 3000 µm of the chip with gaps of 50–500 µm, in order to obtain defined lanes of 
comparable shape (only the straight part of lanes was included in the analyses).
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non-activated HUVEC nor to the supporting polystyrene
slides (not shown).
Concentration of C-reactive protein measured in whole 
blood
In order to determine whether whole blood could be
injected in the microfluidic system and analyzed for indi-
vidual components, a sandwich-immunoassay for human
CRP was chosen. Whole blood was spiked with CRP (anti-
gen) to give final concentrations in the range of 5–80 mg/
liter above the endogenous level (which is typically less
than 2 mg/liter for a healthy individual). The spiked
blood was guided over antibodies against CRP and insulin
(capture antibodies), which had been covalently
Analysis of the lane variation using the streptavidin-biotin  affinity reaction Figure 2
Analysis of the lane variation using the streptavidin-
biotin affinity reaction. A microfluidic chamber with the 
same design and dimensions as described in Figure 1, but 
etched into a silicon chip and closed by bonding, was coated 
with streptavidin. Fluorescein-labeled biotin was then hydro-
dynamically guided in 50-µm-wide lanes over an area of 1000 
× 1000 µm (arrows indicate the directions of flow). Ten 
lanes were applied evenly, and the procedure was repeated 
in a perpendicular direction, resulting in a grid of 100 inter-
sections. The bended shape of the lanes in the lower and left 
part of the photomicrograph resulted from the hydrody-
namic bending of the flow due to the quadratic shape of the 
microfluidic chamber. Scale bar, 100 µm.
Cell-membrane integrity of chinese hamster ovary cells on  exposure to saponin Figure 3
Cell-membrane integrity of chinese hamster ovary 
cells on exposure to saponin. Immobilized cells were 
exposed for 30 s to saponin guided hydrodynamically into 
200-µm-wide lanes (arrow indicate the direction of flow). 
Calcein AM and ethidium homodimer-1 were then applied in 
the same positions of the flow chamber. Calcein AM enters 
all cells, and is enzymatically converted to green-fluorescent 
calcein in the cytoplasm. Cells with an intact plasma mem-
brane (viable cells) retain calcein, and thus fluoresce green. 
Only cells with a compromised plasma membrane (dead 
cells) take up ethidium homodimer-1. The red fluorescence 
of ethidium homodimer-1 is strongly enhanced once it inter-
acts with the nucleic acids of the cell. The ratio of dead (red) 
to viable (green) CHO cells increased with increasing con-
centration of saponin. Scale bar, 100 µm.
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Adhesion of mononuclear leukocytes to activated human umbillical vein endothelial cells Figure 4
Adhesion of mononuclear leukocytes to activated human umbillical vein endothelial cells. (A): HUVEC were incu-
bated with TNF-α for 6 hr and then stained for CD54, CD62E and CD106 by secondary immunofluorescence (FITC-conju-
gated secondary antibody). CD54, CD62E and CD106 were all induced by TNF-α, and were present in the plasma membrane 
and around the nuclei (stained blue by DAPI). IgG1 with an irrelevant specificity (isotype control) did not give staining of the 
cells. Scale bar, 50 µm. (B): Mononuclear leukocytes from two individuals (black bars: individual 1; white bars: individual 2) 
were stained with BCECF-AM, given 10 or 100 ng/ml of both MCP-1 and MIP-1α, and then hydrodynamically guided in 500-
µm-wide lanes at 10 nl/s (0.75 dyn/cm2) for 10 min over a confluent monolayer of TNF-α-activated HUVEC. HUVEC were 
washed (15 dyn/cm2), and the number of adherent blood cells was counted. Chemokine-activated mononuclear leukocytes did 
not adhere to non-activated HUVEC or to the supporting polystyrene slides (not shown). (C): In three different experiments, 
mononuclear leukocytes from individual 1 were mixed with MCP-1 and MIP-1α (both at 10 ng/ml), and aliquots of this leuko-
cyte-chemokine mixture were applied to TNF-α-activated HUVEC immediately or after a 10, 20, 30 or 40 min preincubation 
at 37°C. The leukocytes were guided over HUVEC in 200-µm-wide lanes at 4.0 nl/s (0.75 dyn/cm2) for 5 min, and had thus 
been in contact with the chemokines for 0–5, 10–15, 20–25, 30–35 or 40–45 min, as indicated on the x-axis. HUVEC were 
washed (15 dyn/cm2), and the number of adherent blood cells was counted (counts are normalized because different counting 
frames were used). Mononuclear leukocytes activated with chemokines for any of the exposure times did not adhere to non-
activated HUVEC (not shown).
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immobilized on an activated glass slide. Bound CRP was
subsequently detected with a Cy3-labeled antibody. No
clotting of the system occurred, and a linear relationship
between fluorescence signal (area under average intensity
curve) and CRP concentration was obtained (Figure 5).
The capture antibody against insulin was included to
determine the specificity of the assay, and all lanes were
guided over both capture antibodies. No fluorescence sig-
nals were detected in the area of the slide coated with cap-
ture antibodies against insulin.
Discussion
The many diverse biological applications of microfluidic
systems, including analysis [14,15] and sorting [16,17] of
cells and molecules, reflect the broad potential in biolog-
ical sciences of working with sample in small volumes
under dynamic laminar-flow conditions [1,14]. Microflu-
idic systems for bioanalytical applications take advantage
of the small distances between analytes in sample fluids
and cells or molecules immobilized in the system. The
unique feature of the microfluidic system presented in
this article is the ability to position sample in streams of
adjustable width and flow rate over the surface of stand-
ard slides (and other formats that fit in the docking sta-
tion). Patterning of the slide surface, for example, by
immobilizing cells and molecules onto it, does not have
to be performed in the microfluidic system, but can be
done under standard static conditions.
In order to study the variation within and between lanes
produced by hydrodynamic guiding, a two-dimensional
grid was made by guiding fluorophore-labeled biotin over
immobilized streptavidin in two dimensions sequen-
tially. Although the lanes were equally spaced and uni-
form, and the grid thus appeared regular, the fluorescence
intensity decreased slightly along the length of the lanes,
indicating that the binding sites for biotin were not satu-
rated. In most assays, saturation is not desirable for at
least one of the components involved. Decreasing binding
or activity along the length of lanes should, therefore, be
taken into consideration when designing/evaluating
assays based on hydrodynamic guiding. In the analyses of
cell-membrane integrity, cell adhesion, and CRP concen-
tration presented in this article, regions for analysis were
determined by shifting a frame laterally between lanes,
and not along lanes. This approach also avoids the bias
introduced if regions of interest are chosen on the basis of
visual inspection.
Analyses based on microfluidics are fast and require only
a small amount of sample material. In the microfluidic
system described in the present article, the feeding capil-
lary held 10 µl of sample, which is the minimum volume
of sample needed for producing a lane by hydrodynamic
guiding in this system. Shorter feeding capillaries can be
used if less sample is available, and longer feeding
capillaries should be used if high flow rates and/or wide
lanes are needed for prolonged exposures. The time
required for completing a single lane depends on how
many substances that the lane should be sequentially
exposed to, and the duration of these exposures. In the
analyses of cell-membrane integrity, cell adhesion, and
CRP concentration each lane was completed in approxi-
mately 2 min, 6–11 min, and 2 min, respectively (does
not include time to prepare sample and time to record and
analyze the image). For completing a series of 5–7 lanes,
including setup and analysis, but not preparation of cells,
30–90 min was typically required.
In-vitro toxicology testing has gained attention during the
last decade, as regulatory issues are limiting the use of
animals for this purpose, and because many different
mammalian cell lines have become available for screening
purposes [18,19]. A microfluidic format of a standard
assay for cell-membrane integrity was established, in
which a set of dilutions of a compound can be guided over
cells immobilized on a surface, followed by a staining for
cell viability. In this microfluidic format of the assay, the
membrane damaging effect of a given compound, for
example, a drug candidate from a combinatorial library or
a natural source, can be determined by using only a few
microliters of sample material (10 µl in the system
described here) and a minimum processing time (two
minutes per sample/lane). As an example of this, the
membrane damaging effect of saponin was shown on
CHO cells.
Microfluidics can also be used to study cell-cell interac-
tions, for example, to simulate the early events of transen-
dothelial migration of leukocytes, which is pivotal for
both acute and chronic inflammation, and also involved
in the atherosclerotic process. Leukocytes enter tissues
through the post-capillary venules, a process that requires
recognition of and firm adhesion to the endothelium:
CD54, CD62E and CD106, which are membrane-bound
ligands for leukocyte LFA-1/Mac-1, CD162 and VLA-4,
respectively, are induced on endothelium overlying
inflamed tissues. In chronic inflammation, cytokines
from tissue macrophages, for example, TNF-α, are respon-
sible, at least in part, for the endothelial-cell activation
required for adhesion of mononuclear leukocytes (mono-
cytes and lymphocytes). For firm adhesion, mononuclear
leukocytes require activation of receptors already present
in the cell membrane. This conformational change might
be induced by MCP-1 and MIP-1α, and increased expres-
sion levels of these chemokines have been demonstrated
in joints of individuals suffering from rheumatoid arthri-
tis [20,21].BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/10
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Immunoassay for C-reactive protein in whole blood Figure 5
Immunoassay for C-reactive protein in whole blood. Capture antibodies against CRP and insulin (control) were cova-
lently immobilized on an activated glass slide. Whole blood spiked with CRP to give a concentration of 0, 5, 10, 20, 40 or 80 
mg/liter above the endogenous level was hydrodynamically guided over both capture antibodies for 2.0 s. The lane was then 
washed, and Cy3-labeled secondary antibody was applied to the lane. After all lanes were completed, the entire slide was 
scanned in a fluorescence scanner. (A): Segments of this scan (each 68 × 470 pixel), showing a fluorescence signal from the area 
with anti-CRP capture antibody, but not from the area with anti-insulin capture antibody (control). The width of the lanes 
increased with increasing concentration of CRP, possibly due to diffusion of the antigen. Scale bar, 100 µm. (B): The mean fluo-
rescence intensities of the 470 columns of pixels of the upper segment in (A) plotted against pixel column number. (C): The flu-
orescence signal from the area with anti-CRP capture antibody increased with increasing CRP concentration. The relationship 
between CRP concentration and area under the mean fluorescence intensity curve in (B) was linear (●  R2 = 0.97), whereas the 
relationship between CRP concentration and peak in the mean fluorescence intensity curve in (B) was better described by a 
model of saturation (❍  MFIpeak = Ka + µ × [CCRP / (CCRP + Ks)]).
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In the present study, a microfluidic model of the recogni-
tion events that occur between leukocytes and endothelial
cells in chronic inflammation was established. In this
model, firm adhesion of mononuclear leukocytes
required that HUVEC had been treated with TNF-α, which
induces the expression of CD54, CD62E and CD106. By
contrast, monocytes adhere even to non-activated HUVEC
in static models of leukocyte-endothelial cell adhesion
[22]. This basal level of adhesion has been shown to be
CD18 dependent, and in static assays, a pretreatment of
the mononuclear leukocytes with antibodies against
CD18 may be necessary [23]. In the microfluidic system,
adhesion of mononuclear leukocytes also required the
presence of chemokines: MCP-1 and MIP-1α increased
the number of adherent mononuclear leukocytes 14–25
fold. This effect of the chemokines was instant and
decreased with time of preincubation with the blood cells.
Because adhesion in the dynamic in-vitro model described
here is TNF- and chemokine-dependent, it may be a good
alternative or supplement to static assays for leukocyte-
endothelial cell interactions.
CRP, an acute phase reactant synthesized by the liver, is
widely used as a marker of inflammation and has been
shown to correlate with the risk of coronary vascular dis-
ease [24]. Whereas the commercially available assays for
detection of CRP in serum are based on conventional
immunoassays [25], assays that can be performed on less
sample or on crude sample material have been developed,
for example, a microchip-based system for measurement
of CRP in serum [26], and a micro-particle based assay for
CRP detection in whole blood [27].
The present study demonstrates that CRP can be detected
in a dose-dependent manner in unprocessed whole blood
in a microfluidic system. The relationship between fluo-
rescence signal and CRP concentration was linear in the
range tested (5–80 mg/liter of CRP) when the width of the
lanes was taken into consideration. The analysis is fast
(one sample completed in two minutes) and has a high
degree of specificity, as no signal was detected over the
area coated with an irrelevant capture antibody. In addi-
tion to the specificity of the antibody, the short reaction
time between antigen and capture antibody might also
contribute to the specificity of the assay.
Conclusions
Microfluidic systems combine the advantages of perform-
ing bioassays under laminar flow with the possibility of
having multiple experimental conditions on a small
surface area. By contrast to microfluidic systems based on
physically separated reaction chambers, the microfluidic
system described here achieves this by hydrodynamic
guiding of sample over an open surface area. In the three
biomedical applications demonstrated, the use of hydro-
dynamic guiding made multiple and dynamic experimen-
tal conditions on a small surface area possible. The
described microfluidic system is widely applicable, and
allows the use of surfaces patterned in the micro- and
nanometer scale under static conditions, and even analy-
sis of slides with thin tissue sections. The ability to change
the direction of flow, in order to produce two-dimen-
sional grids, adds to the flexibility of the system, and
increases the number of possible reactions per surface area
even further.
Methods
Microfluidic system
The microfluidic system consisted of a microfluidic chip,
a docking station, and a liquid-controlling unit. The
microfluidic chip was produced in poly(methyl methacr-
ylate) using standard mechanic machining technology,
mainly milling, turning and drilling. The flow chamber of
the chip was quadratic with rounded corners (radius =
200 µm) and had the following dimensions (length ×
width × depth): 5000 × 5000 × 40 µm. Each of the two
flow directions held drillings for three influent streams (Ø
= 200 µm for the sample fluid, and Ø = 300 µm for the
guiding streams) and one effluent stream (Ø = 300 µm).
A T-junction was placed upstream the flow chamber in
order to bypass surplus sample fluid or to flush the flow
chamber. All influent and effluent channels were glued
with ultra-violet curable glue (Threebond, Germany) to
non-polar fused silica capillaries (Sigma Chemical Co., St.
Louis, MO) with an inside diameter of 250 µm for guiding
and effluent flows, and an inside diameter of 100 µm for
sample flows. The docking station, which provided the
mechanical force for sealing between the microfluidic
chip and the slide with the biological material, was man-
ufactured using metal-cutting technology. The docking
station was placed on the stage of an Axioskop 2 epifluo-
rescence microscope (Zeiss, Switzerland) on which a CCD
camera (Princeton Instruments RTE/CCD-1317-K/1;
Roper Scientific, Germany) was mounted.
The microfluidic chip was connected via the capillaries to
a liquid-controlling unit with three high-precision syringe
pumps (XL3000; TECAN Systems, San Jose, CA) and three
solenoid valves (Lee, Westbrook, CT). Multiport injection
valves (ValcoVICI; Switzerland) were used for sample
introduction and change of flow direction from one
dimension to the other. Fluidics was controlled with Lab-
View 6.0i (National Instruments, Austin, TX) software
installed on a Pentium-class computer, allowing com-
mand transmission between the communication ports
and the pumps and valves.
Lane-variation analysis
A custom-made microfluidic chamber with the same
design and dimensions as described above was etchedBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/10
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into a silicon chip (SLS µ-Technology, Germany) and
closed by bonding pyrex glass directly onto the structure.
For coating of the chamber with streptavidin, the follow-
ing protocol was followed: the chamber was washed with
phosphate-buffered saline (PBS) with 0.05% Tween 20
(v/v; Merck, Germany); incubated with 0.01% poly-L-
lysine (w/v; Sigma Chemical Co.) in PBS for 10 min at
room temperature; flushed with PBS; incubated with
12.5% glutaraldehyde (v/v; Sigma Chemical Co.) in PBS
for 45 min at room temperature; flushed with PBS; incu-
bated with 40 mM ethanolamine (Merck) in PBS for 15
min at room temperature; and finally flushed with PBS.
The chip was then connected to the pumps and valves, via
the non-polar fused silica capillaries glued to the struc-
ture, and placed on the stage of the microscope. Fluores-
cein-labeled biotin (1.0 µM in PBS; Sigma Chemical Co.)
was hydrodynamically guided in 50-µm-wide lanes over
an area of 1000 × 1000 µm. The lanes were produced at a
guiding-stream flow rate of 6.0 µl/s and a sample flow rate
of 60 nl/s for 10 s. When 10 lanes had been completed,
the flow direction was changed, and another 10 lanes
were positioned perpendicularly to the first set of lanes.
An image (8 bit, RGB) of the green fluorescence (excita-
tion at 495 nm and emmission at 515 nm) was recorded
on the CCD camera.
Cells
Chinese hamster ovary (CHO) cells (American Type Cul-
ture Collection, Manassas, VA) were grown in Ham's F-12
medium (with 2.0 mM L-glutamine) supplemented with
10% heat-inactivated (56°C, 30 min) newborn calf
serum, 100 IU/ml penicillin and 100 µg/ml streptomycin
(all from BioWhittaker, Belgium). The cells were seeded in
fibronectin-coated (20 µg/ml, 37°C for 2 hr; Invitrogen,
Carlsbad, CA) glass slide flasks (Nunc, Denmark), and
incubated until confluency at 37°C in a humidified
atmosphere of 5% CO2 in air.
Buffy coat from two healthy human individuals was
obtained from the local blood bank and diluted 1:1 in
RPMI 1640 (BioWhittaker). Mononuclear leukocytes were
isolated by density centrifugation (800 × g, 30 min) of 25
ml diluted buffy coat on 20 ml Lymphoprep (Axis-Shield,
Norway). Cells in the interphase were harvested, washed
twice in RPMI 1640 (500 × g, 5 min), resuspended in
RPMI 1640 with 50% heat-inactivated fetal bovine serum
(FBS, v/v; BioWhittaker) and 10% dimethylsulphoxide
(v/v; Sigma Chemical Co.), and frozen in the vapor phase
over liquid nitrogen. Mononuclear leukocytes for flow
assays were thawed, washed once in RPMI 1640, and incu-
bated in Hanks' balanced salt solution (HBSS; Sigma
Chemical Co.) with 10 µM 2',7'-bis-2-carboxyethyl-5 (and
-6)-carboxyfluorescein-acetoxymethyl ester (BCECF-AM;
Molecular Probes, Eugene, OR) for 30 min at room tem-
perature. The cells were then centrifuged (500 × g, 5 min),
resuspended in RPMI 1640, and kept at 5°C. Just prior to
use in flow assays, cells were heated to 37°C, then given
MIP-1α and MCP-1 (to a final concentration of 10 or 100
ng/ml of each chemokine; both from R&D Systems, UK).
Aliquots of the leukocyte-chemokine mixture were
applied to the endothelial-cell layer immediately or after
a 10, 20, 30 or 40 min preincubation at 37°C.
HUVEC were obtained from PromoCell (Germany), and
grown in Endothelial cell growth medium (PromoCell) at
37°C in a humidified atmosphere of 5% CO2 in air.
HUVEC in passage 4–6 were plated at 5000 cells/cm2 and
grown until confluency in polystyrene slide flasks (Nunc).
In order to activate HUVEC, TNF-α (10 ng/ml; R&D Sys-
tems) was added to the medium 6 hr before use in flow
assays.
In order to demonstrate TNF-α-mediated induction of
CD54, CD62E and CD106, HUVEC were stained by
secondary immunofluorescence. The cells were washed
with PBS, fixed in 4% paraformaldehyde (w/v) in PBS for
20 min (room temperature), air dried, washed with PBS,
incubated with absolute ethanol for 2 min, washed with
PBS, incubated with PBS with 5% horse serum (v/v) and
0.1% Triton X-100 (v/v) (both from Sigma Chemical Co.)
for 60 min, and then incubated with PBS with 1% horse
serum (v/v), 0.1% Triton X-100 (v/v), and 10 µg/ml of
mouse IgG1 against human CD54, CD62E, CD106 or an
irrelevant antigen (isotype control) (all antibodies were
from R&D Systems) for 2 hr at room temperature. HUVEC
were then washed with PBS, incubated for 30 min (room
temperature) with FITC-conjugated goat anti-mouse IgG
(30 µg/ml; Sigma Chemical Co.), washed with PBS again,
counterstained with 4',6-diamidino-2-phenylindole
(DAPI, 0.2 µg/ml; Molecular Probes), washed in distilled
water and finally mounted in FluoroGuard (Bio-Rad, Her-
cules, CA).
Cell-membrane integrity assay
A slide with CHO cells, prepared as described above, was
inserted in the docking station, and the docking station
was placed on a heating plate (37°C; Linkam Scientific
Instruments, UK) on the stage of the microscope. HBSS
was applied to the cells at 2.0 µl/s (corresponding to a
shear stress of 15 dyn/cm2) for 5 min to test adherence.
Solutions of saponin (0.008%, 0.010%, 0.012%, 0.013%,
0.014%, and 0.020% in HBSS; w/v; Sigma Chemical Co.),
and HBSS only (to determine the background level of cell
death), were addressed one at a time at 80 nl/s for 30 s in
200-µm-wide lanes (15 dyn/cm2 shear stress). After each
lane, HBSS with 2.0 µM calcein AM (green fluorescence;
Molecular Probes) and 4.0 µM ethidium homodimer-1
(red fluorescence; Molecular Probes) was applied at 80 nl/
s for 60 s in the same position of the flow chamber. After
completion of each lane, images of the green and redBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/10
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fluorescence (excitation at 495 nm and emmission at 515
or 635 nm, respectively) of the same part of the lane were
recorded on the CCD camera. The images were overlaid
and saved in 8-bit RGB format.
Leukocyte-endothelial cell adhesion model
A slide with a confluent monolayer of HUVEC was
inserted in the docking station, and the docking station
was placed on the heating plate (37°C) on the stage of the
microscope. Endothelial cell growth medium was applied
to the cells at 2.0 µl/s (corresponding to a shear stress of
15 dyn/cm2) for 5 min to test adherence. BCECF-AM-
treated mononuclear leukocytes, prepared as described
above, were hydrodynamically guided over the HUVEC
monolayer at 4.0 nl/s or 10 nl/s for 5 or 10 min in 200- or
500-µm-wide lanes, respectively (both corresponding to a
shear stress of 0.75 dyn/cm2). Each lane was washed with
Endothelial cell growth medium immediately (2.0 µl/s for
60 s), and an image (8 bit, RGB) of the green fluorescence
(excitation at 495 nm and emmission at 515 nm) of the
straight part of the lane was recorded on the CCD camera.
Detection of C-reactive protein in whole blood
A custom-made FlexiPerm silicone stamp (two chambers
of 2150 × 5000 µm placed side-to-side and separated by
700  µm; In Vitro Systems & Services, Germany) was
mounted on a SpotOn glass slide coated with an acid
chloride functional polymer for covalent attachment of
amines (Scandinavian Micro Biodevices, Denmark). The
two chambers confined by the stamp and the slide were
incubated at 4°C over night with polyclonal rabbit anti-
bodies against human CRP or insulin (0.1 mg/ml in PBS;
Dako, Denmark). The chambers were washed with PBS
and incubated for 30 min at room temperature with a
blocking solution consisting of 5% skim milk powder (w/
v; Merck) and 0.2% Tween 20 (v/v) in PBS. The blocking
solution was replaced with PBS, the stamp was removed,
and the slide was washed for 30 min in 100 ml PBS (gen-
tle stirring).
The polyclonal antibody against CRP was labeled with
Cy3 monofunctional dye according to the manufacturer
(Amersham Biosciences, UK). Excess dye was removed by
gel filtration on a Superdex 75 column (Amersham Bio-
sciences). The labeling gave a Cy3/IgG molecular ratio of
3.
The slide was mounted in the docking station with both
capture antibodies represented in the flow chamber.
Heparinized whole blood from a healthy human individ-
ual was spiked with Human serum CRP calibrator (Dako)
to give concentrations of 0, 5, 10, 20, 40 and 80 mg/liter
above the endogenous level (which is typically less than 2
mg/liter for a healthy individual). The CRP calibrator was
at a concentration of 160 mg/liter. In order to avoid differ-
ent degrees of dilution of the blood when spiked to obtain
low and high concentrations of CRP, the CRP calibrator
was diluted in PBS, and then mixed 1:1 with the blood.
For each concentration of CRP, the blood was injected
immediately after spiking and guided into a lane at a sam-
ple flow rate of 20 nl/s and a total flow rate of 2.0 µl/s.
After 2.0 s, the lane was washed with PBS at 2.0 µl/s for 30
s. Cy3-labeled detection antibody (0.3 µM in PBS) was
then applied to the same lane for 30 s (sample flow rate,
20 nl/s; total flow rate, 2.0 µl/s), and the lane was finally
washed with PBS. The assay was performed at room
temperature. When all lanes were completed, the entire
slide was scanned in an ArrayWorx fluorescence scanner
(Applied Precision, Issaquah, WA). Intensity measure-
ments were performed using Matlab 6.0 software (The
MathWorks, Natick, MA).
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